Xeris Biopharma Holdings Inc [XERS] Investment Appeal on the Rise

Xeris Biopharma Holdings Inc’s recently made public that its Director Schmid John P. acquired Company’s shares for reported $9720.0 on Mar 14 ’24. In the deal valued at $2.16 per share,4,500 shares were bought. As a result of this transaction, Schmid John P. now holds 11,000 shares worth roughly $21010.0. Then, SHERMAN JEFFREY W bought […]

Understanding the Risks of Investing in Xeris Biopharma Holdings Inc (XERS)

Xeris Biopharma Holdings Inc’s recent filing unveils that its Director Schmid John P. acquired Company’s shares for reported $9720.0 on Mar 14 ’24. In the deal valued at $2.16 per share,4,500 shares were bought. As a result of this transaction, Schmid John P. now holds 11,000 shares worth roughly $22440.0. Then, SHERMAN JEFFREY W bought […]

A Guide To The Risks Of Investing In Xeris Biopharma Holdings Inc (XERS)

Xeris Biopharma Holdings Inc’s filing revealed that its Director Schmid John P. acquired Company’s shares for reported $9720.0 on Mar 14 ’24. In the deal valued at $2.16 per share,4,500 shares were bought. As a result of this transaction, Schmid John P. now holds 11,000 shares worth roughly $24310.0. Then, SHERMAN JEFFREY W bought 5,400 […]

Investing in Xeris Biopharma Holdings Inc (XERS): What You Must Know

In a filing, Xeris Biopharma Holdings Inc revealed its Director Schmid John P. acquired Company’s shares for reported $9720.0 on Mar 14 ’24. In the deal valued at $2.16 per share,4,500 shares were bought. As a result of this transaction, Schmid John P. now holds 11,000 shares worth roughly $23210.0. Then, SHERMAN JEFFREY W bought […]